(Q45762323)

15 December 2017

title

Hepatitis A and travel amongst Nova Scotia postsecondary students: evidence for a targeted vs. universal immunization strategy (English)

1 reference

15 December 2017

0 references

1 reference

4

1 reference

15 December 2017

Shelly A McNeil

object named as

Shelly McNeil

3

0 references

Scott A Halperin

6

object named as

Scott A Halperin

1 reference

15 December 2017

Katherine Matheson

1

1 reference

15 December 2017

Beth Halperin

2

1 reference

15 December 2017

Donna Mackinnon-Cameron

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

16 October 2010

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

28

1 reference

15 December 2017

issue

51

1 reference

15 December 2017

page(s)

8105-8111

1 reference

15 December 2017

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

1 reference

Clinical manifestations of hepatitis A: recent experience in a community teaching hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Autoimmune hepatitis triggered by acute hepatitis A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

The cost of hepatitis A infections in American adolescents and adults in 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Risk of hepatitis A in travellers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Hepatitis A in Swedish travellers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Sexual transmission of hepatitis A in homosexual men: incidence and mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Outbreaks of hepatitis A among illicit drug users, Oklahoma, 1984-87.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Seroepidemiology of hepatitis A in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Incidence of hepatitis A in the United States in the era of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Effect of Hepatitis A Vaccination Programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Epidemiological patterns of hepatitis A in different parts of the world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Participant-collected, mail-delivered oral fluid specimens can replace traditional serosurveys: a demonstration-of-feasibility survey of hepatitis A virus-specific antibodies in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Stability of saliva for measuring HIV in the tropics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Stability of total and rubella-specific IgG in oral fluid samples: the effect of time and temperature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Success stories in the implementation of universal hepatitis B vaccination: an update on Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

Cost-utility of universal hepatitis A vaccination in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

New, ultrasensitive enzyme immunoassay for detecting vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.107

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.09.107

1 reference

15 December 2017

1 reference

15 December 2017